Opicapone

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Journal: Annals of medicine

Published: March 05, 2026

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Journal: Zeitschrift fur Gerontologie und Geriatrie

Published: December 19, 2025

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Journal: Frontiers in neurology

Published: November 24, 2025

Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study.

Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study.

Journal: Frontiers in neurology

Published: November 03, 2025

Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America.

Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America.

Journal: Frontiers in pharmacology

Published: October 14, 2025

Faith, fasting, and well-being: Emirates Neurology Society consensus guidelines on safe Ramadan fasting in Parkinson's disease.

Faith, fasting, and well-being: Emirates Neurology Society consensus guidelines on safe Ramadan fasting in Parkinson's disease.

Journal: Frontiers in neurology

Published: October 08, 2025

Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations.

Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations.

Journal: Frontiers in neurology

Published: September 29, 2025

Opicapone for the Treatment of Nocturnal Hypokinesia in Patients With Parkinson's Disease: An Open-Label Pilot Clinical Trial.

Opicapone for the Treatment of Nocturnal Hypokinesia in Patients With Parkinson's Disease: An Open-Label Pilot Clinical Trial.

Journal: Journal of movement disorders

Published: September 15, 2025

Parkinson Disease.

Parkinson Disease.

Journal: Continuum (Minneapolis, Minn.)

Published: August 01, 2025

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

Journal: Journal of neurology

Published: August 01, 2025

Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability.

Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability.

Journal: Current neurology and neuroscience reports

Published: July 01, 2025

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Journal: Parkinsonism & related disorders

Published: June 24, 2025

Showing 1-12 of 162

Last Updated: 04/28/2026